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Sunday, February 26, 2012 137awere normalized to the transcript level of the housekeeping gene GAPD. With-
out normalization no correlation was obtained, indicating that cell-to-cell var-
iability in mRNA isolation represents most of the experimental noise. This
improved technique should prove very valuable for studying the molecular
background of diversity in excitability in normal and disease conditions.
Support: FWO-G.0449.11, BOF-GOA-2004-University of Antwerp
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Mechanism of Action of the Photoswitch Molecule QAQ
Christian Herold, Alexandre Mourot, Richard H. Kramer.
UC Berkeley, Berkeley, CA, USA.
Controlling neuronal excitability with light has emerged as a powerful and
widely used approach in Neuroscience. Optogenetic tools function by enabling
light to activate exogenously expressed ion channels that over-power endoge-
nous electrophysiogical processes.
In contrast, we have introduced a non-genetic approach to conferring light sen-
sitivity on neurons that involves photochemical tools that regulate endogenous
ion channels. Specifically, the design of the molecule QAQ is built around an
azobenzene photoswitch group flanked by two symmetric quaternary ammo-
nium groups which confer the ability to intracellularly block voltage-gated so-
dium, potassium and calcium channels. Blocking can be regulated by rapid and
reversible photoisomerization of the central azobenzene group from trans to cis
configuration upon 380 or 500nm light illumination, respectively. QAQ in its
trans configuration blocks ion conduction through open channels enabling
light-sensitive silencing of neurons while conversion to the cis configuration re-
lieves the block.
Given its double-charged character, QAQ is membrane-impermeable but it can
enter cells through TRPV1 or P2X7 receptors if they are active. Since TRPV1 is
mainly expressed in dorsal root ganglia neurons and participates in the percep-
tion of various external stimuli and pain, QAQ functions as a local anesthetic
inhibiting neuronal excitibitly after cell entry.
In that context, we have demonstrated that QAQ can modify nociception after
selective loading of active pain neurons. However, the precise biophysical
mechanism of action of QAQ on voltage-gated channels remains unclear.
Therefore, we conducted an extended biophysical characterization using ex-
cised inside-out patches to elucidate binding characteristics of both QAQ con-
figurations on a reporter channel, the voltage-gated potassium channel Shaker.
Experiments involving mutations of Shaker and monitoring of QAQ trapping
upon gate closure revealed interactions of QAQ with the channel. In summary,
we examined the state-dependent persistence of blocking and our findings lead
to multi-state binding model.
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Pharmacology of Slo2.1 Channel Activation and Block
Priyanka Garg, Michael Sanguinetti.
CVRTI, University of Utah, Salt lake city, UT, USA.
Intracellular sodium regulated Slo2.1 channels are selectively expressed in the
brain and the heart. They are closed under normal physiological and ionic con-
ditions, but markedly activated after elevation of [Naþ]i, for example during
myocardial ischemia. These channels are also activated by fenamates without
elevation of intracellular sodium. Fenamates (N-arylated derivatives of anthra-
nilic acid with different substituents on the aryl ring) are non-steroidal anti-
inflammatory drugs that function as mixed agonists for Slo2.1 channels. We
performed Quantitative Structure Activity Relationship (QSAR) studies on
these drugs and established the requirement of a minimal pharmacophore de-
fined as fenamic acid (2-(phenylamino) benzoic acid) for Slo2.1 channel acti-
vation. Meclofenamic acid was found to be the most potent activator of Slo2.1
channels expressed in Xenopus oocytes with an EC50 of 90 mM. We further re-
port that verapamil, an open-state dependent blocker, blocks Slo2.1 (IC50 = 15
mM) and has free access to its binding site even in the non-activated state of the
channel. The permanently charged, membrane impermeant analogue of verap-
amil, D890 was used to address sidedness of block and location of the binding
site in the channel protein. These observations indicate that unlike other potas-
sium channels, the canonical S6 bundle crossing in Slo2.1 channels is always in
an open configuration and does not function as the primary activation gate.
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Structural Bases Supporting the Critical Role of the CRAC Motif Nearest
to the N-End of Slo1 Cytosolic C-Tail in Determining the BK Channel
Sensitivity to Membrane Cholesterol
Aditya K. Singh1, Jacob McMillan2, Anna N. Bukiya1, Brittany Burton2,
Abby L. Parrill2, Alex M. Dopico1.
1The University of Tennessee Hlth. Sci. Ctr., Memphis, TN, USA,
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We demonstrated that the CRAC domain nearest the N-end of BK channel-
forming cbv1 subunits (CRAC4) is the main region that provides cholesterol(CLR) sensitivity to cbv1, the signature CRAC4 Y450 being critical. Here
we combined amino acid substitutions in CRAC4, bilayer electrophysiology,
and computational dynamics to advance structural bases of CRAC4-CLR inter-
actions. First, trcbv1-CRAC4 constructs including V444A or K453A were in-
sensitive to CLR. Second, trcbv1-CRAC4 K453R retained CLR sensitivity.
Third, trcbv1-CRAC4 Y450F was CLR-resistant. However, Y429F in the S6-
CRAC4 linker rendered CLR-sensitive channels. Therefore, CLR sensitivity
of trcbv1-CRAC4 is determined by the key residues that define a CRAC motif
(Epand, 2006). Moreover, the substitution Y450F in CRAC4 was sufficient to
blunt the CLR sensitivity of full-length BK channels. Computational simula-
tions of full-length cbv1 CTD and trcbv1 CTD-CRAC4 showed CLR remain-
ing in CRAC4 for the majority of the simulation with CLRD ring near Y450 for
over one-third of the simulation. CLR A ring resided predominantly near E417,
which hydrogen bonded with CRAC4 through the Y450 hydroxyl, also indicat-
ing that CLR stayed close to CRAC4. Conversely, the highest residence for
trcbv1 CTD-CRAC4 Y450F was for CLR D ring and tail, which remained
near H409 and Y336, respectively, neither of which are part of CRAC4. Nota-
bly higher mobility of positions 450 and K453 in CRAC4 were also noted in the
simulations of trcbv1-CRAC4 Y450F, indicating that a stable interaction site
for CLR is lacking when the Y450 hydroxyl is not present to hydrogen bond
to E417. Data provide a structural interpretation for the prominence of
CRAC4 and its Y450 in providing CLR-sensitivity to trcbv1-CRAC4 and
full-length BK channels. Support: R01-HL104631;R37-AA011560 (AMD);
UTHSC NI Fellowship (AKS).
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Molecular Mechanism of Enhancement of CaV1.2 Channels by b2-Adren-
ergic Receptors
Jeffery T. Juergens, William A. Sather.
University of Colorado Denver, Aurora, CO, USA.
In neurons, b2-adrenergic (b2AR) enhancement of the activity of L-type
voltage-gated calcium channels (Cav1.2) is important for certain forms of syn-
aptic plasticity. The mechanism of regulation is thought to involve phosphory-
lation by protein kinase A (PKA) of residues in the C-terminus of Cav1.2. A
PKA-anchoring protein (AKAP) is required for efficient phosphorylation and
enhancement of Cav1.2 channel activity. Neuronally-localized AKAP79, un-
like all other AKAPs, binds the Ca2þ/calmodulin-activated phosphatase calci-
neurin (CaN), and thus anchors CaN along with PKA within the Cav1.2-b2AR
complex. To study b2AR enhancement of Cav1.2 channel activity, we have
used whole-cell patch-clamp to voltage-clamp currents from tsA-201 cells
transfected with constructs for full-length Cav1.2, the channel’s accessory sub-
units (b2b, a2d), AKAP79 and the b2AR. With this system, we have found that
b2AR agonist (isoproterenol, Iso) can enhance Ba
2þ current ~25%. Enhance-
ment by Iso was nearly absent (~5%) when current was carried by Ca2þ. Can-
didates that could support Ca2þ-dependent suppression of enhancement include
CaN and the Ca2þ/calmodulin-dependent kinase CaMKII, which is also scaf-
folded to the channel. Sites phosphorylated by PKA and suspected of involve-
ment in enhancement include residues S1700, T1704 and S1928 in the CaV1.2
C-terminus. Substitution of alanine at any of these three sites of phosphoryla-
tion by PKA abolished enhancement by Iso. To further investigate the mecha-
nism of enhancement, we used the ratio of Ba2þ tail current (60 mV) to gating
charge at reversal as an index of the efficiency of channel opening (Itail/Qgate
coupling efficiency). For wild-type (WT) channels, coupling efficiency was in-
creased by Iso. Phosphorylation site mutations (S1700, S1928, S1700þT1704)
decreased coupling efficiency in the absence of Iso, and abolished the Iso-
induced increase in coupling efficiency observed for WT channels, consistent
with the inability of agonist to enhance current carried by the mutants.
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Hindlimb unloading (HU)-induced muscle disuse is characterized by atrophy
and slow-to-fast phenotype shift of slow-twitch soleus muscle (Sol), including
adaptation of sarcolemma ion channel expression and function. Pleiotrophin
(PTN) is an heparin-binding growth factor produced also by muscle with proan-
giogenic, neurotrophic, and postsynaptic action. Here we evaluate the effects of
PTN on Sol properties after 14-days HU using PTN-overexpressing mice. After
138a Sunday, February 26, 2012HU, Sol fiber cross-sectional area, as an index of atrophy, is reduced in both
WT and PTN. In basal conditions, PTN overexpression increases type I and de-
creases type IIA fibers, suggesting that Sol becomes slower. HU has no effect
on Sol fiber typing in transgenic mice, suggesting that PTN may counteract the
HU-induced slow-to-fast shift. HU increases the resting chloride conductance
of sarcolemma by 36% in WT mice and only by 17% in PTN mice, as expected
from phenotype shift. HU increases gene expression of ClC-1 chloride and
Nav1.4 sodium channels, and decreases expression of Ca2þ-activated Kþ
channels (realtime-PCR), in both WT and PTN mice. Although expression of
ATP-sensitive Kþ channels subunits is similar in WT and PTN Sol in basal
conditions, HU increases their expression only in PTN mice. In parallel, the
resting potassium conductance of Sol fibers is increased after HU only in
PTN mice. Expression of the proangiogenic genes, VEGF-A and KDR, is de-
creased after HU inWTmice. Surprisingly, PTN overexpression also decreases
expression of VEGF-A and KDR in basal conditions, so that no further effect of
HU is observed in PTN mice. The results suggest that PTN overexpression may
modify expression and function of chloride and potassium channels, thereby




Modeling Ca2D Induced Ca2D Release Between Neighboring Ryanodine
Receptors
Michael J. Yonkunas, Michael Fill, Dirk Gillespie.
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In the heart, Ca2þ is released from the sarcoplasmic reticulum (SR) through
ryanodine receptors (RyR). A small Ca2þ trigger activates a RyR, which
then mediates a larger Ca2þ flux sufficient to activate neighboring RyRs. The
inherent positive feedback of Ca2þ induced Ca2þ release (CICR) should cause
Ca2þ release to continue until the SR is empty. This phenomenon does not oc-
cur in cells. In order to understand why, we have developed a simple physical
model to describe CICR using simulations of discrete RyR channels on a two
dimensional grid. RyR open probability (Po) is defined through a traditional
two-site Hill function comprised of one cytosolic Ca2þ activation and one cy-
tosolic Ca2þ inactivation sites per subunit. The diffusion equation for a steady
state point source of Ca2þ current defines the Ca2þ concentration everywhere in
the system. Single channel experimental Ca2þ dissociation constant values
were used. Our Metropolis Monte Carlo simulations quantitatively reproduce
Po’s measured as a function of cytosolic Ca
2þ for both single RyR as well as
a two-RyR channel system reconstituted in bilayers. Our simulations suggest
a mechanism for CICR termination requiring only a reduction in unitary
Ca2þ current. Small changes in Ca2þ current produce large and sudden changes
in overall activity in RyR arrays. Our simulations show reducing current may
terminate release well before depletion of the SR at Ca2þ loads consistent
with experiment. This current-termination occurs independently from any
form of luminal regulation or coupled gating. Thus, we propose CICR termina-
tion may be due to a drop in single channel Ca2þ current as local intra-SR Ca2þ
levels fall during release.
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Caveolin-3 Expression in the Adult Rat Myocardium
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University of Leeds, Leeds, United Kingdom.
Drugs such as statins, which modify cholesterol synthesis and transport, have
the capacity to alter the expression of many proteins through transcriptional
regulation via sterol regulatory elements (SRE) in their promoters. One group
of such proteins are the caveolins, structural and regulatory elements of caveo-
lae. Caveolae regulate diverse processes including [Ca2þ]i handling and
adrenergic responsiveness in the adult cardiac myocyte [1]. Given the choles-
terol- and caveolin-dependence of caveolae, we hypothesised that statin treat-
ment would affect myocyte caveolae with consequences for contractile
function. Male Wistar rats were treated with 40 mg/kg simvastatin for 2 weeks.
Serum cholesterol was significantly reduced following statin treatment (from
554 to 460 mg/ml, n=11; P<0.01, Student’s t-test), and this was associated
with a corresponding 23% reduction in myocardial cholesterol (n=6, P<0.05).
Caveolin 1 expression was attenuated by 84% in the statin-treated group (n=3,
P<0.001), but surprisingly this was associated with a 404% increase in caveolin
3 expression (n=6, P<0.05). Changes in caveolin expression were accompanied
by a significant decrease in time to half relaxation and time to half decay of the
[Ca2þ]i transient infield-stimulated isolated ventricularmyocytes (n=13-20 cells
from3-4 hearts; P<0.05). These data show, for the first time, that in vivo simvas-
tatin treatment influences the profile of caveolin expression in the myocardiumand increases lusitropy. This represents a novel pleiotropic effect of statins
which would be predicted to improve diastolic filling of the heart in situ.
This work was funded by the British Heart Foundation
[1] Calaghan S, White E. Caveolae modulate excitation-contraction coupling
and beta2-adrenergic signalling in adult rat ventricular myocytes. Cardiovasc
Res 2006;69:816-24.
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Rebecca A. Bayliss, Duncan Bloor-Young, Grant C. Churchill,
Derek A. Terrar.
University of Oxford, Oxford, United Kingdom.
NAADP is a calcium mobilising compound acting via a two-pool mechanism
(1). In both ventricular and atrial myocytes, NAADP increases cellular calcium
transients through enhancement of SR calcium load (2,3).
In ventricular myocytes Ned-19, a non-competitive antagonist of the NAADP
receptor, abolishes the contractile response to NAADP(4). Furthermore, both
bafilomycin and Ned-19 decrease whole-cell calcium transients and, after
Ned-19 exposure, bafilomycin has no further effect (4).
Tissue level of NAADP is raised after isoprenaline perfusion in whole heart,
consistent with a role for NAADP in the beta-adrenergic response (2).
This project aimed to measure the response of atrial myocytes to NAADP and
investigate the relevance of the pathway to beta-adrenergic signalling.
Enzymatically-isolated guinea pig atrial myocytes were loaded with fluo-5F
calcium indicator dye and NPE-caged NAADP (5mM). Cells were stimulated
during superfusion with physiological salt solution and NAADP released by
UV-photolysis. Whole-cell calcium transients were measured with a photomul-
tiplier system. All data are given mean5SEM with statistical significance con-
sidered as p<0.05.
Flash-photolysis of NAADP increased atrial calcium transients by 67515%
(p<0.05, n=7), becoming significant 3min after photolysis and reaching
a peak at 12min. This increase was prevented by 1mM patch-applied Ned-19.
In field-stimulated atrial myocytes, bafilomycin (100nM) significantly reduced
cellular calcium transients (by 1955%, n=6) and inhibited enhancement of the
calcium transient by isoprenaline (3nM), reducing it from a 6358% (n=9) to
a 3659% (n=6) increase (p<0.05).
These data support the two-pool model for NAADP actions in cardiac atrial
myocytes, suggest the NAADP system is constitutively active and indicate
a physiological role in beta-adrenergic signalling.
1)Churchill and Galione EMBOJ (2001) 20: 2666-2671.
2)Macgregor et al. Cell Calcium (2007) 41:537-546.
3)Collins et al. Cell Calcium (2011) In press.
4)Elson et al. Biophysical Journal (2011) 100, 81a-82a.
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Ca2D Handling
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We have recently demonstrated that there may be a direct link between energy
substrate utilization and contractile function. Mice that have increased cardiac
lipid storage and oxidation as a result of fatty acid transport protein 1 overex-
pression in the heart exhibit cellular diastolic dysfunction and acute exposure of
myocytes to the long chain fatty acid palmitate attenuates contractility by dis-
rupting E-C coupling. Glucose and long chain fatty acids are typical energy
substrates that support cardiac function; however, cardiac myocytes can oxi-
dize a variety of substrates for energy generation. For example, the short chain
fatty acid, acetate, can be oxidized in preference to glucose in some circum-
stances. In the present study, we explore the effects of acute exposure to acetate
or pyruvate on contractile function of isolated mouse ventricular myocytes.
Acute exposure of myocytes to Tyrode solution supplemented with 10 mM
sodium acetate causes a marked, but transient, decrease in sarcomere shortening
(1.4950.20% vs. 5.5850.49% in control) and a significant increase in diastolic
sarcomere length (1.7750.01 mm vs. 1.8150.01 mm in control) that persists in
the continued presence of acetate for up to 60 minutes. Pyruvate (the major mi-
tochondrial substrate), and dichloroacetate (indirectly stimulates mitochondrial
pyruvate oxidation) cause similar effects. Interestingly, pretreatment of cells
with the mitochondrial Ca2þ uptake blocker, Ru-360 (10 mM), markedly sup-
pressed the effect of acetate on bothmyocyte contractile amplitude and diastolic
sarcomere length. Taken together, the data suggest that 1) acute exposure to ac-
etate or pyruvate can modulate both systolic and diastolic cardiac function and
that 2) mitochondrial Ca2þ uptake seems to be a key mediator of this effect.
